Lateral wall collapse from sleep endoscopy and airflow shape predicts hypoglossal nerve stimulation efficacy in obstructive sleep apnoea.
Daniel Vena, Sara Op de Beeck, Hyungchae Yang...
https://pubmed.ncbi.nlm.nih.gov/40774807/Actively Recruiting
Led by Brigham and Women's Hospital · Updated on 2026-09-16
72
Participants Needed
1
Research Sites
26 weeks
Total Duration
Researchers are studying adults with obstructive sleep apnea OSA who experience airway collapse from the side of the upper airway during sleep. The trial aims to find out if removing the tonsils at the time of hypoglossal nerve stimulation HGNS improves treatment compared to HGNS alone. The study focuses on patients with moderate-to-severe OSA and complete oropharyngeal lateral wall collapse, a condition that may reduce HGNS effectiveness. Participants will be randomly assigned to receive either HGNS combined with tonsillectomy or HGNS alone. Both groups will undergo standard postoperative device activation and adjustment. In the HGNS-alone group, participants with ongoing OSA may later have tonsillectomy as standard care. An optional substudy will include detailed sleep testing to understand how these treatments impact airway collapsibility. During the study, participants will complete sleep studies, questionnaires, and assessments before and after treatment. Follow-up visits will include sleep testing to evaluate treatment effectiveness and safety. Researchers will measure changes in apnea-hypopnea index and other patient-reported outcomes after about one month of optimized therapy. The total study duration extends through the treatment period and follow-up assessments.
CONDITIONS
Combination Tonsillectomy and Hypoglossal Nerve Stimulation for OSA Patients With Lateral Pharyngeal Collapse
D
Daniel Vena, PhD
D
Dillon Gilbertson, BASc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Brigham and Women's Hospital
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | HGNS plus tonsillectomy | HGNS alone |
|---|---|---|
| What it is | Combination of hypoglossal nerve stimulation device implantation with concurrent tonsil removal performed during the same surgical procedure. | Hypoglossal nerve stimulation device implantation without removing the tonsils. |
| Role in trial | Investigational combination arm randomised to test whether adding tonsillectomy improves HGNS effectiveness. | Active comparator arm receiving HGNS implantation alone. |
| Primary use | To reduce severity of obstructive sleep apnea in patients with lateral pharyngeal collapse. | To reduce severity of obstructive sleep apnea in patients with lateral pharyngeal collapse. |
| How it is given or performed | Surgical implantation of a hypoglossal nerve stimulator concurrently with tonsil removal. | Surgical implantation of a hypoglossal nerve stimulator without operating on the tonsils. |
| Evidence status | Early single‑center observational data suggest adding tonsillectomy to HGNS may lead to greater reductions in AHI and higher odds of treatment response. | HGNS alone is established as effective in CPAP‑intolerant patients with appropriate airway anatomy, though outcomes may be reduced in those with lateral wall collapse. |
| Important risks | Risks include standard surgical risks plus those associated with implanting a device and removing tonsils. | Risks include surgical implantation of a device, anesthesia, infection, and possible nerve‑related effects. |
| Important limitations | Evidence is limited to preliminary observational data; randomized outcomes are pending. | Effectiveness may be reduced in patients with oropharyngeal lateral wall collapse; predictive tools and generalizability remain evolving. |
| Patient impact | May lead to greater improvement in sleep apnea severity compared with HGNS alone, based on early data. | Provides established therapeutic option for those intolerant of CPAP, but may underperform in presence of lateral wall collapse. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 1 month
Participants receive hypoglossal nerve stimulation with or without tonsillectomy according to their assigned group. Postoperative device activation and titration are performed to optimize therapy.
Multiple follow-up visits for device adjustment and evaluation
Duration - Up to several months after treatment
Participants complete follow-up sleep studies and questionnaires to assess treatment effectiveness and airway physiology. Additional testing may be done in a subset to measure airway collapsibility.
Scheduled follow-up visits and sleep testing
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Daniel Vena, Sara Op de Beeck, Hyungchae Yang...
https://pubmed.ncbi.nlm.nih.gov/40774807/Phillip Huyett, David T Kent, Mark A D'Agostino...
https://pubmed.ncbi.nlm.nih.gov/33443811/Phillip Huyett, Andrew Wellman, Victoria Caruso...
https://pubmed.ncbi.nlm.nih.gov/39189155/Brigham and Women's Hospital
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Collaborating Sponsor